Hong Kong Biotech Stock News

SEHK:1310
SEHK:1310Telecom

HKBN (SEHK:1310) Valuation Check After Exclusive Venustech Cybersecurity Distribution Agreement

Why the Venustech agreement matters for HKBN HKBN (SEHK:1310) has signed a Distribution Framework Agreement with Venustech, giving it exclusive rights in Hong Kong and Macao to distribute Venus Firewall products for the first year of the deal. See our latest analysis for HKBN. HKBN’s 1 month share price return of 14.12% and year to date share price return of 12.48% suggest building momentum, while the 41.55% 1 year total shareholder return points to a much stronger payoff for investors who...
SEHK:119
SEHK:119Real Estate

Poly Property Group (SEHK:119) Valuation Check After New Medium Term Note Issuance And Recent Share Price Gains

Poly Property Group (SEHK:119) caught investor attention after its subsidiary, Shanghai Poly Property, issued a second tranche of 2026 medium term notes. The issuance raised RMB500 million at a 2.95% coupon to replenish funds used for prior debt repayment. See our latest analysis for Poly Property Group. The recent RMB500 million note issuance comes at a time when Poly Property Group’s 90 day share price return of 23.24% and 1 year total shareholder return of 58.44% point to building momentum...
SEHK:3696
SEHK:3696Life Sciences

Assessing InSilico Medicine Cayman TopCo (SEHK:3696) Valuation After Strong Year To Date Share Price Gains

Setting the scene for InSilico Medicine Cayman TopCo InSilico Medicine Cayman TopCo (SEHK:3696) has drawn fresh attention after recent share price moves, with a 1 day return of about 1.6% and a 7 day gain of roughly 4.7%. See our latest analysis for InSilico Medicine Cayman TopCo. The latest moves sit within a much stronger trend, with a year to date share price return of about 58.9% at a current share price of roughly HK$59.7. This suggests momentum has been building as investors reassess...
SEHK:1211
SEHK:1211Auto

BYD (SEHK:1211) Valuation Check As P/E Premium Contrasts With Cash Flow Upside Signals

Recent share performance and business scale Without a clear single news catalyst, you might be looking at BYD (SEHK:1211) simply because its recent share performance and business size stand out among Hong Kong listed auto and battery groups. Over the past month, BYD shares have returned about 5.9%, while the past 3 months show a modest 1.3% decline. On a 1 year view, the total return figure provided is 14.2%. The company reports revenue of CN¥841.1b and net income of CN¥38.3b. This reflects a...